1. Home
  2. VTRS vs TTEK Comparison

VTRS vs TTEK Comparison

Compare VTRS & TTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VTRS
  • TTEK
  • Stock Information
  • Founded
  • VTRS 1961
  • TTEK 1966
  • Country
  • VTRS United States
  • TTEK United States
  • Employees
  • VTRS N/A
  • TTEK N/A
  • Industry
  • VTRS Medicinal Chemicals and Botanical Products
  • TTEK Military/Government/Technical
  • Sector
  • VTRS Health Care
  • TTEK Consumer Discretionary
  • Exchange
  • VTRS Nasdaq
  • TTEK Nasdaq
  • Market Cap
  • VTRS 10.2B
  • TTEK 9.4B
  • IPO Year
  • VTRS N/A
  • TTEK 1991
  • Fundamental
  • Price
  • VTRS $8.83
  • TTEK $35.19
  • Analyst Decision
  • VTRS Hold
  • TTEK Buy
  • Analyst Count
  • VTRS 5
  • TTEK 5
  • Target Price
  • VTRS $10.40
  • TTEK $40.00
  • AVG Volume (30 Days)
  • VTRS 16.2M
  • TTEK 1.9M
  • Earning Date
  • VTRS 08-07-2025
  • TTEK 07-30-2025
  • Dividend Yield
  • VTRS 5.42%
  • TTEK 0.74%
  • EPS Growth
  • VTRS N/A
  • TTEK N/A
  • EPS
  • VTRS N/A
  • TTEK 0.69
  • Revenue
  • VTRS $14,330,200,000.00
  • TTEK $4,555,101,000.00
  • Revenue This Year
  • VTRS N/A
  • TTEK $8.15
  • Revenue Next Year
  • VTRS $1.89
  • TTEK N/A
  • P/E Ratio
  • VTRS N/A
  • TTEK $51.38
  • Revenue Growth
  • VTRS N/A
  • TTEK 10.76
  • 52 Week Low
  • VTRS $6.85
  • TTEK $27.27
  • 52 Week High
  • VTRS $13.55
  • TTEK $51.20
  • Technical
  • Relative Strength Index (RSI)
  • VTRS 51.17
  • TTEK 52.87
  • Support Level
  • VTRS $8.66
  • TTEK $34.88
  • Resistance Level
  • VTRS $9.19
  • TTEK $36.55
  • Average True Range (ATR)
  • VTRS 0.23
  • TTEK 0.74
  • MACD
  • VTRS -0.01
  • TTEK -0.16
  • Stochastic Oscillator
  • VTRS 48.11
  • TTEK 46.46

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. Remaining 60% of sales is derived from its portfolio of legacy products which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

About TTEK Tetra Tech Inc.

Tetra Tech Inc provides consulting and engineering services for environmental, infrastructure, resource management, energy, and international development markets. It specializes in providing water-related services for public and private clients. It designs infrastructure, facilities, and other structures with complex plans and resource management. Tetra Tech has two reportable segments. Its Government Services Group (GSG) segment includes activities with U.S. government clients (federal, state and local) and activities with development agencies world-wide. Commercial/International Services Group (CIG) segment, which derives maximum revenue, includes activities with U.S. commercial clients and international clients other than development agencies.

Share on Social Networks: